Crossmark

The effect of increased frequency of hemodialysis on vitamin C concentrations: an ancillary study of the randomized Frequent Hemodialysis Network (FHN) daily trial

Crossref DOI link: https://doi.org/10.1186/s12882-019-1311-4

Published Online: 2019-05-17

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Raimann, Jochen G. https://orcid.org/0000-0002-8954-2783
Abbas, Samer R.

Liu, Li

Larive, Brett

Beck, Gerald

Kotanko, Peter

Levin, Nathan W.

Handelman, Garry
License Information

Text and Data Mining valid from 2019-05-17

Version of Record valid from 2019-05-17
More Information

Article History

Received: 10 August 2018

Accepted: 25 March 2019

First Online: 17 May 2019

Ethics approval and consent to participate

: This manuscript reports data from an ancillary study to the Frequent Hemodialysis Network (FHN) Daily Trial ( #NCT00264758). This ancillary study aimed to recruit all patients that were enrolled as subjects during the entire active study period into the prospective, randomized, controlled FHN Daily Trial.The study was approved by the Institutional Review Board of Beth Israel Medical Center and was conducted according to the Declaration of Helsinki. All patients signed informed consent.

: Not applicable.

: Peter Kotanko holds stock in Fresenius Medical Care North America. All other authors have nothing to disclose.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below